Minority Participation in Clinical Trials

Category

ACCC Joins ASCO in Efforts to Improve Minority Representation in Cancer Clinical Trials

The Association of Community Cancer Centers (ACCC) has partnered with the American Society of Clinical Oncology (ASCO) in a collaborative effort to improve the participation of racial and ethnic minority populations in cancer clinical trials. The organizations call on...

Engaging Racial and Ethnic Minority Patient Populations in COVID-19 Clinical Trials

CTTI is hosting a timely webinar Thursday June 18 at Noon ET to discuss the importance and urgency of meaningful engagement of racial and ethnic minority communities in COVID-19 clinical trials. Using insights gleaned from a survey of key stakeholders across the...

University of Alabama Research Studies Whether Bias is Impacting Cancer Clinical Trials’ Participation

The University of Alabama at Birmingham recently completed a study raising questions about racial bias in cancer research trials. Apparently, a subtle, or in some case not-so-subtle, bias against racial minorities—especially Blacks and Latinos—could, in some cases,...

Entertainment Industry-backed “Stand Up to Cancer” Targets Underrepresented Minorities Populations for Clinical Trial Participation

Stand Up to Cancer (SU2C) announced its initiative to increase minority representation in cancer and clinical trials. This initiative is aimed at reducing racial and ethnic disparities in cancer research and improving outcomes for minority populations. They will fund...

Pin It on Pinterest